Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiwen Liu, Lixuan Lin, Qi Cai, Caichen Li, Haoxiang Xu, Ruiqi Zeng, Mingtong Zhang, Xinyi Qiu, Shiqi Chen, Xizhe Zhang, Linchong Huang, Wenhua Liang & Jianxing He. (2023) Do testosterone and sex hormone-binding globulin affect cancer risk? A Mendelian randomization and bioinformatics study. The Aging Male 26:1.
Read now
Read now
Articles from other publishers (17)
Bangbei Wan, Likui Lu & Cai Lv. (2023) Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone‐binding globulin on prostate cancer. Andrology 11:6, pages 1023-1030.
Crossref
Crossref
Alexander Dias, Mark N. Brook, Elizabeth K. Bancroft, Elizabeth C. Page, Anthony Chamberlain, Sibel Saya, Jan Amin, Christos Mikropoulos, Natalie Taylor, Kathryn Myhill, Sarah Thomas, Edward Saunders, Tokhir Dadaev, Daniel Leongamornlert, Thomas Dyrsø Jensen, D. Gareth Evans, Cezary Cybulski, Annelie Liljegren, Soo H. Teo, Lucy Side, Zsofia Kote‐Jarai & Rosalind A. Eeles. (2023)
Serum testosterone and prostate cancer in men with germline
BRCA1/2
pathogenic variants
. BJUI Compass 4:3, pages 361-373.
Crossref
Crossref
Rebecca Ahlin, Natalja P. Nørskov, Sanna Nybacka, Rikard Landberg, Viktor Skokic, Johan Stranne, Andreas Josefsson, Gunnar Steineck & Maria Hedelin. (2023) Effects on Serum Hormone Concentrations after a Dietary Phytoestrogen Intervention in Patients with Prostate Cancer: A Randomized Controlled Trial. Nutrients 15:7, pages 1792.
Crossref
Crossref
Zahra Tahmasebi Fard. (2022) The effect of sex hormone-binding globulin gene polymorphisms on the serum level of SHBG hormone in the men with prostate cancer. Meta Gene 31, pages 101000.
Crossref
Crossref
Matteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, Mihai Dorin Vartolomei, Rocco Damiano, Francesco Cantiello, Fabio Crocerossa, Sisto Perdonà, Paola Del Prete, Giovanni Cordima, Gennaro Musi, Francesco Del Giudice, Gian Maria Busetto, Benjamin I. Chung, Angelo Porreca, Pasquale Ditonno, Michele Battaglia & Daniela Terracciano. (2020) Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies. World Journal of Urology 39:6, pages 1861-1867.
Crossref
Crossref
Qiyou Wan, Yan Xie, Yuanzhong Zhou & Xubo Shen. (2020) Research progress on the relationship between sex hormone‐binding globulin and male reproductive system diseases. Andrologia 53:1.
Crossref
Crossref
Urszula Rychlik. (2020) Assessment of testosterone and its fraction in patients with locally advanced prostate cancer and in patients with primary metastatic disease. Diagnostyka Laboratoryjna 55:4, pages 257-270.
Crossref
Crossref
Yann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, Camélia Radulescu, Mathieu Rouanne, Marc Schneider, Sylvie Krish, Morgan Rouprêt, Sarah J. Drouin, Eva Comperat, Marc Galiano, Xavier Cathelineau, Pierre Validire, Vincent Molinié, Jean Fiet, Franck Giton, Thierry Lebret & Henry Botto. (2018) Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results. Hormones and Cancer 10:1, pages 36-44.
Crossref
Crossref
Takeshi Ujike, Motohide Uemura, Atsunari Kawashima, Akira Nagahara, Kazutoshi Fujita, Yasushi Miyagawa & Norio Nonomura. (2018) A novel model to predict positive prostate biopsy based on serum androgen level. Endocrine-Related Cancer 25:1, pages 59-67.
Crossref
Crossref
Ahmed Abdelbaset-Ismail, Daniel Pedziwiatr, Gabriela Schneider, Jacek Niklinski, Radoslaw Charkiewicz, Marcin Moniuszko, Magda Kucia & Mariusz Z. Ratajczak. (2017) Pituitary sex hormones enhance the pro-metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase-1. International Journal of Oncology 50:1, pages 317-328.
Crossref
Crossref
Ana Elisa LohmannPamela J. GoodwinRowan T. ChlebowskiKathy PanVuk StambolicRyan J.O. Dowling. (2016) Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome. Journal of Clinical Oncology 34:35, pages 4249-4255.
Crossref
Crossref
Markus A. Thaler, Vanadin Seifert-Klauss & Peter B. Luppa. (2015) The biomarker sex hormone-binding globulin ? From established applications to emerging trends in clinical medicine. Best Practice & Research Clinical Endocrinology & Metabolism 29:5, pages 749-760.
Crossref
Crossref
Ola Bratt & Hans Lilja. (2015) Serum markers in prostate cancer detection. Current Opinion in Urology 25:1, pages 59-64.
Crossref
Crossref
Qi-Qi Mao, Yi-Wei Lin, Hong Chen, Kai Yang, De-Bo Kong & Hai Jiang. (2014) Monitoring of prostate cancer growth and metastasis using a PSA luciferase report plasmid in a mouse model. Asian Pacific Journal of Tropical Medicine 7:11, pages 879-883.
Crossref
Crossref
Michael Kirby. (2014) The importance of knowing testosterone levels in patients with prostate cancer. BJU International 114:2, pages 164-165.
Crossref
Crossref
Frank Friedersdorff, Philipp Manus, Kurt Miller, Michael Lein, Klaus Jung & Carsten Stephan. (2014) Serum testosterone improves the accuracy of Prostate Health Index for the detection of prostate cancer. Clinical Biochemistry 47:10-11, pages 916-920.
Crossref
Crossref
Tijl Vermassen, Charles Van Praet, Dieter Vanderschaeghe, Thomas Maenhout, Nicolaas Lumen, Nico Callewaert, Piet Hoebeke, Simon Van Belle, Sylvie Rottey & Joris Delanghe. (2014) Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer. ELECTROPHORESIS 35:7, pages 1017-1024.
Crossref
Crossref